JP4260139B2 - Cell culture membrane support device - Google Patents

Cell culture membrane support device Download PDF

Info

Publication number
JP4260139B2
JP4260139B2 JP2005172996A JP2005172996A JP4260139B2 JP 4260139 B2 JP4260139 B2 JP 4260139B2 JP 2005172996 A JP2005172996 A JP 2005172996A JP 2005172996 A JP2005172996 A JP 2005172996A JP 4260139 B2 JP4260139 B2 JP 4260139B2
Authority
JP
Japan
Prior art keywords
membrane
culture
cells
amniotic membrane
corneal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2005172996A
Other languages
Japanese (ja)
Other versions
JP2005348736A (en
Inventor
正克 朴
在一 安
英権 徐
寅根 張
連浩 申
斗勲 李
▲へ▼勲 尹
啓用 宋
恩敬 梁
基鎬 金
Original Assignee
株式会社バイオランド
正克 朴
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 株式会社バイオランド, 正克 朴 filed Critical 株式会社バイオランド
Publication of JP2005348736A publication Critical patent/JP2005348736A/en
Application granted granted Critical
Publication of JP4260139B2 publication Critical patent/JP4260139B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00Constructional details, e.g. recesses, hinges
    • C12M23/48Holding appliances; Racks; Supports
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M25/00Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
    • C12M25/02Membranes; Filters

Landscapes

  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Sustainable Development (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Clinical Laboratory Science (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Materials For Medical Uses (AREA)

Description

本発明は、細胞培養用膜の支持装置に関するものであって、より詳しくは、細胞培養用膜を支持するための別途の締付け手段を用いることなく膜の上下両面で目的とする細胞の培養が可能であるだけでなく、膜に付着した細胞の気液界面培養の際に、傾斜振動培養が可能である細胞培養用膜の支持装置に関する。   The present invention relates to a support device for a cell culture membrane, and more particularly, to culture a desired cell on both the upper and lower sides of the membrane without using separate fastening means for supporting the cell culture membrane. The present invention also relates to a support device for a membrane for cell culture, which is capable of performing tilted vibration culture during gas-liquid interface culture of cells attached to the membrane.

科学の発達と共に医学の飛躍的な発展によって、現在は殆どすべての臓器を移植できる水準にまで至った。しかし、このような臓器移植技術の発達が人類の健康増進には非常に重要な役割を果たすが、臓器移植手術の技術的な難しさ、高コスト及び免疫抑制剤の使用による副作用などの限界がある。このような状況下で、一部の科学者は人工的に生体組織又は臓器を作って移植する方法の研究を行い、その結果、組織工学(tissue engineering)という新しい分野が誕生することになった。   Due to the rapid development of medicine along with the development of science, it has now reached a level where almost all organs can be transplanted. However, the development of such organ transplantation technology plays a very important role in promoting human health, but there are limitations such as technical difficulties in organ transplantation surgery, high costs, and side effects caused by the use of immunosuppressive agents. is there. Under these circumstances, some scientists have conducted research on methods of artificially creating and transplanting living tissues or organs, resulting in the creation of a new field called tissue engineering. .

組織工学は、細胞を生体適合性(biocompatibility)基質に3次元的に培養して細胞−基質複合体を製造し、これを用いて生体組織及び臓器を再生する分野に関する学問であって、細胞工学技術と生体材料技術が組合されて人工組織及び臓器開発、遺伝子及び細胞治療分野などに適用されている。より具体的に、骨と軟骨、筋肉、皮膚、肝、腎臓、心臓、弁膜などの人工臓器の開発及び組織工学的再生を通じた交替、血管構成細胞と生分解性ポリマーを用いて作った人工血管の開発及び透明な生体材料に角膜上皮細胞を移植して作った人工角膜などの製造に該組織工学技術が適用され得る。   Tissue engineering is a discipline related to the field of producing cells-matrix complexes by three-dimensionally culturing cells on a biocompatibility substrate, and using this to regenerate living tissues and organs. Technology and biomaterial technology are combined and applied in the field of artificial tissue and organ development, gene and cell therapy. More specifically, development of artificial organs such as bone and cartilage, muscle, skin, liver, kidney, heart, and valve membrane, and replacement through tissue engineering regeneration, artificial blood vessels made using vascular constituent cells and biodegradable polymers The tissue engineering technique can be applied to the development of the above and the production of an artificial cornea made by transplanting corneal epithelial cells into a transparent biomaterial.

このような組織工学技術を用いた生体組織及び臓器再生のためには、まず生体適合性膜(biocompatible membrane)又は基質膜上で細胞を培養する必要があり、このように膜に細胞を培養するためには膜を支持する器具又は装置が必要になる。   In order to regenerate biological tissues and organs using such tissue engineering techniques, it is first necessary to culture cells on a biocompatible membrane or a substrate membrane, and thus culture cells on the membrane. This requires an instrument or device that supports the membrane.

前記膜の具体的な例として羊膜(amniotic membrane)が用いられ得る。羊膜は胎児膜の最内側にある膜であって、母体側からの各種感染及び免疫反応などから胎児を保護する重要な防壁の役割を果たし、厚い基底膜と無血管性間質からなっている(Jerzy et al., Ann. of Trans., 4:85-90 (1999); Nancy et al., Aorn Jour., 39:894-899 (1984))。このような羊膜は、現在やけど患者のドレッシング(dressing)と移植後カバー(cover)として用いられるだけではなく、神経冠、気道、粘膜組織の再構成(reconstruction)の支持体として用いらている。また、目球の表面の異常を有しているモデル又は患者に羊膜を角膜上皮細胞の自家移植のための基質として用いて移植した場合もある(Koizumi et al., Cornea, 19:65-71 (2000); Tsai et al., The New Eng. Jour. of Med., 343:86-93 (2000))。   As a specific example of the membrane, an amniotic membrane can be used. The amniotic membrane is the innermost membrane of the fetal membrane and serves as an important barrier to protect the fetus from various infections and immune reactions from the maternal side, consisting of a thick basement membrane and an avascular stroma (Jerzy et al., Ann. Of Trans., 4: 85-90 (1999); Nancy et al., Aorn Jour., 39: 894-899 (1984)). Such amniotic membranes are currently used not only as a dressing and post-transplant cover for burn patients, but also as a support for the reconstruction of neural crests, airways, and mucosal tissues. In some cases, a model or patient having an abnormal surface of the eyeball is transplanted using amniotic membrane as a substrate for autologous transplantation of corneal epithelial cells (Koizumi et al., Cornea, 19: 65-71 (2000); Tsai et al., The New Eng. Jour. Of Med., 343: 86-93 (2000)).

一方、前記羊膜を支持するための器具と関連して、野口等の文献(Noguchi et al., Biochem. and Biophy. res. com., 210:302-309 (1995))は、羊膜を2個の同心円のポリカルボナート(polycarbonate)リング(ring)からなる上部リングと下部リングとの間に固定させ、気道上皮細胞を羊膜上皮面に接種して単層培養し、分化させるための組織支持装置(tissue holding device)を開示しており、米国特許第4,446,234号は天然障壁組織(natural barrier tissue)との細胞相互作用を評価するためのin vitroアッセイ方法において哺乳類胎盤に由来する羊膜が基質組織に用いられ得ることを明らかにすると共に、羊膜を上部リングと下部リングとの間にボルトのような締付け手段を用いて固定させることを一例として提示している。   On the other hand, in connection with the instrument for supporting the amniotic membrane, Noguchi et al., Biochem. And Biophy. Res. Com., 210: 302-309 (1995)) described two amniotic membranes. Tissue support device for fixing between upper and lower rings consisting of concentric polycarbonate rings, inoculating airway epithelial cells on the amnion epithelial surface, monolayer culture, and differentiation US Pat. No. 4,446,234 discloses an amniotic membrane derived from a mammalian placenta in an in vitro assay method for assessing cell interaction with a natural barrier tissue. As an example, the amnion is fixed between the upper ring and the lower ring by using a fastening means such as a bolt.

また、既存の羊膜上で角膜上皮細胞を培養する実験と研究方法ではカルチャープレートインサート(culture plate insert; Corning Inc., Corning, NY)又はトレンスウェルインサート(TranswellTM insert)のような器具を用いたが、このような商業用器具は細胞培養の前に羊膜を縫合し、移植前に縫合糸を除去しなければならないという不便があり、また、羊膜の上面での培養のみが可能であるため、角膜の三種類の細胞のうち、一種の細胞しか培養できないという問題があった。 In addition, in experiments and research methods for culturing corneal epithelial cells on existing amniotic membrane, a device such as a culture plate insert (Corning Inc., Corning, NY) or Trentwell insert (Transwell TM insert) was used. However, such a commercial instrument has the inconvenience that the amniotic membrane must be sutured before cell culture and the suture must be removed before transplantation, and can only be cultured on the upper surface of the amniotic membrane, Among the three types of cells of the cornea, there was a problem that only one type of cell could be cultured.

米国特許第4,446,234号U.S. Pat. No. 4,446,234 Jerzy et al., Ann. of Trans., 4:85-90 (1999); Nancy et al., Aorn Jour., 39:894-899 (1984)Jerzy et al., Ann. Of Trans., 4: 85-90 (1999); Nancy et al., Aorn Jour., 39: 894-899 (1984) Koizumi et al., Cornea, 19:65-71 (2000); Tsai et al., The New Eng. Jour. of Med., 343:86-93 (2000)Koizumi et al., Cornea, 19: 65-71 (2000); Tsai et al., The New Eng. Jour. Of Med., 343: 86-93 (2000) Noguchi et al., Biochem. and Biophy. res. com., 210:302-309 (1995)Noguchi et al., Biochem. And Biophy.res.com., 210: 302-309 (1995)

本発明は、前記のような問題を解決するために案出されたものであって、本発明の目的は、羊膜縫合過程と移植する際に縫合糸を除去する過程における不便を解消し、膜の上下両面で目的とする細胞の培養が可能なだけでなく、膜に付着した細胞の気液界面培養の際に傾斜振動培養が可能な細胞培養用膜の支持装置を提供することである。   The present invention has been devised to solve the above-mentioned problems, and the object of the present invention is to eliminate the inconvenience in the amnion stitching process and the process of removing the suture when transplanted, It is an object of the present invention to provide a support device for a cell culture membrane that allows not only the desired cell culture on both the upper and lower sides of the cell but also the tilted vibration culture during the gas-liquid interface culture of the cells attached to the membrane.

本発明の他の目的は、前記細胞培養用膜の支持装置と膜とを用いて、目的とする細胞を培養する方法を提供することである。   Another object of the present invention is to provide a method for culturing target cells using the cell culture membrane support apparatus and membrane.

前記のような目的を果たすために、本発明は、中央に貫通孔、貫通孔の側面に沿って一方の面に形成された突出部、及び他方の面に3個以上の脚を備えた第1部材;及び中央に貫通孔、貫通孔の側面に沿って一方の面に前記第1部材の突出部を取り込むための受容部、及び他方の面に3個以上の脚(leg)を備えた第2部材を含み、第1部材の突出部と第2部材の受容部はその間に細胞培養用膜を固定させ得るように噛み合う、細胞培養用膜の支持装置を提供する。   In order to achieve the above object, the present invention includes a through hole at the center, a protrusion formed on one surface along the side surface of the through hole, and three or more legs on the other surface. 1 member; and a through hole at the center, a receiving part for taking in the protrusion of the first member along one side surface of the through hole, and three or more legs on the other side Provided is a support device for a cell culture membrane that includes a second member, and the protruding portion of the first member and the receiving portion of the second member mesh with each other so that the membrane for cell culture can be fixed therebetween.

本発明で用いた「再構成」という表現は体外で実際の組織と類似する形態で人工組織を作ることを意味する。   The expression “reconstruction” used in the present invention means making an artificial tissue in a form similar to an actual tissue outside the body.

本発明の細胞培養用膜の支持装置は、別途の締付け手段を用いることなく膜を支持でき、しかも、膜の上下両面で目的とする細胞の培養が可能であり、膜に付着した細胞の気液界面培養の際に傾斜振動培養ができるため組織再構成期間を短縮できる。さらに、このように再構成された組織は毒性用モデルだけでなく移植用にも用いられ得る。   The cell culture membrane support apparatus of the present invention can support a membrane without using a separate fastening means, and can culture a target cell on both the upper and lower surfaces of the membrane. Since tilted vibration culture can be performed during liquid interface culture, the tissue reconstruction period can be shortened. Furthermore, the tissue reconstituted in this way can be used not only for toxicity models but also for transplantation.

以下、本発明を詳しく説明する。
本発明は、組織工学を用いた人工器官の製造において、実際組織を構成する細胞を膜(membrane)上で培養する際に前記膜を支持する役割をする装置を提供することに特徴がある。
Hereinafter, the present invention will be described in detail.
The present invention is characterized by providing an apparatus that plays a role of supporting a membrane when cells constituting actual tissue are cultured on a membrane in the production of a prosthesis using tissue engineering.

具体的に、本発明は中央に貫通孔、貫通孔の側面に沿って一方の面に形成された突出部、及び他方の面に3個以上の脚を備えた第1部材;及び中央に貫通孔、貫通孔の側面に沿って一方の面に前記第1部材の突出部を取り込むための受容部、及び他方の面に3個以上の脚を備えた第2部材を含み、第1部材の突出部と第2部材の受容部とはその間に細胞培養用膜を固定させ得るように噛み合う、細胞培養用膜の支持装置を提供する。   Specifically, the present invention is a first member having a through hole at the center, a protrusion formed on one surface along the side surface of the through hole, and three or more legs on the other surface; A hole, a receiving portion for taking in the protruding portion of the first member on one surface along the side surface of the through-hole, and a second member having three or more legs on the other surface; The protrusion part and the receiving part of the second member provide a support device for the cell culture membrane that is meshed so that the cell culture membrane can be fixed therebetween.

図1a〜図1eは、本発明の第1態様による細胞培養用膜の支持装置に対する斜視図(図1a)、側面分離度(図1b)、平面図(図1c)、側面結合図(図1d)及び設計図(図1e)を示し、図2は、本発明の第1態様によって円型に製造された細胞培養用膜の支持装置に対する写真を示す。以下、添付の図面を参照して説明する。   FIGS. 1a to 1e are a perspective view (FIG. 1a), a side separation degree (FIG. 1b), a plan view (FIG. 1c), and a side coupling diagram (FIG. 1d) for a cell culture membrane support device according to the first embodiment of the present invention. ) And a design drawing (FIG. 1e), and FIG. 2 shows a photograph of the support device for the cell culture membrane manufactured in a circular shape according to the first embodiment of the present invention. Hereinafter, description will be given with reference to the accompanying drawings.

前記第1部材(15)及び第2部材(16)の一方の面に形成された脚(leg)(13)は、第1部材(15)の突出部(12)と第2部材(16)の受容部(14)との間に細胞培養用膜を置いて噛み合うように結合して膜が支持された装置を細胞培養培地に入れて膜で細胞を培養する際、細胞培養培地の底面と膜との間に空間を設けることによって気液界面培養(air liquid interface culture)が可能にする役割をする。   The leg (13) formed on one surface of the first member (15) and the second member (16) is formed by the protruding portion (12) of the first member (15) and the second member (16). When a cell culture membrane is placed between the cell culture medium and the cell culture medium is placed in the cell culture medium and the cell culture medium is cultivated by placing a cell culture membrane between the cell culture medium and the receiving portion (14) of the cell culture medium, the bottom surface of the cell culture medium By providing a space between the membrane, air liquid interface culture can be performed.

気液界面培養はラフトカルチャー(raft culture)とも言い、培養する細胞が付着した膜の下面には培地が、上面には空気が接するようにして培養することを意味する。このように気液界面培養を行う場合、下部からの栄養供給と上部からの空気との接触によって実際組織(例えば、皮膚の上皮細胞)の環境状態と同様な状態で分化を誘導できるという長所がある。   The gas-liquid interface culture is also called raft culture, and means that the medium is cultured on the lower surface of the membrane to which the cells to be cultured adhere and the air is in contact with the upper surface. When performing gas-liquid interface culture in this way, there is an advantage that differentiation can be induced in a state similar to the environmental state of the actual tissue (e.g., epithelial cells of the skin) by contact with the nutrient supply from the lower part and the air from the upper part. is there.

前記脚(13)は培地の流動性を考慮して適正な数を有するように製造され得、前記支持装置の培地上における均衡維持のために3個以上を備えることが好ましい。また、前記脚(13)は細胞培養容器の高さ、細胞培養容器内の培地の量及び培地交替時期などを勘案して様々な高さを有するように製造され得る。脚が高いほど培地交替を頻繁にしなくても良いという長所があるが、高すぎると培地が過度に所要されるという短所があり、脚が低すぎると支持装置内外の培地の流動が適切でないため、培養が十分に行われないという短所がある。具体的に、前記脚は1mm〜5mm、より好ましくは2mm〜4mmの高さを有するように製造されることが好ましい。   The legs (13) may be manufactured to have an appropriate number in consideration of the fluidity of the culture medium, and it is preferable that three or more legs (13) are provided for maintaining the balance of the support device on the culture medium. The legs (13) may be manufactured to have various heights in consideration of the height of the cell culture container, the amount of the medium in the cell culture container, the medium replacement time, and the like. There is an advantage that the medium does not need to be changed frequently as the legs are high, but there is a disadvantage that the medium is excessively required if it is too high, and the flow of the medium inside and outside the support device is not appropriate if the legs are too low. There is a disadvantage that culture is not performed sufficiently. Specifically, the leg is preferably manufactured to have a height of 1 mm to 5 mm, more preferably 2 mm to 4 mm.

前記第1部材(15)の突出部(12)の突出長さは前記第2部材(16)の受容部(14)の受容深さと同一であり、第1部材(15)の突出部(12)と第2部材(16)の受容部(14)との間に細胞培養用膜をおいて両側で力を加えて突出部(12)を受容部(14)に押し入れて組立てれば突出部(12)と受容部(14)が噛み合いながら膜を固定させて支持するようになる。前記受容部(14)は凹溝の形態であることが好ましく、突出部(12)の形状によって多様な形状に製造され得る。   The protruding length of the protruding portion (12) of the first member (15) is the same as the receiving depth of the receiving portion (14) of the second member (16), and the protruding portion (12) of the first member (15). ) And the receiving part (14) of the second member (16) with a membrane for cell culture applied on both sides to push the protruding part (12) into the receiving part (14) and assemble it. The membrane is fixed and supported while meshing (12) and the receiving portion (14). The receiving part 14 is preferably in the form of a concave groove, and can be manufactured in various shapes according to the shape of the protrusion 12.

一方、前記装置の第1部材(15)及び第2部材(16)は細胞が培養される膜の形態及び培養した細胞を移植する部位の形態などを考慮して中央に貫通孔(11)を有する円形又は三角形、四角形などの多角形形態に製造され得るが、羊膜を固定して引っ張る力がすべての方向で一定である円型(ring type)部材に製造されることが好ましい。   On the other hand, the first member (15) and the second member (16) of the device have a through hole (11) in the center in consideration of the form of the membrane in which the cells are cultured and the form of the site where the cultured cells are transplanted. Although it can be manufactured in a circular shape or a polygonal shape such as a triangle or a quadrangle, it is preferably manufactured in a ring type member in which the force for fixing and pulling the amniotic membrane is constant in all directions.

また、前記第1部材(15)及び第2部材(16)の材質としては生体適合性に優れ、流動培養の際に培地に浮かばないほどの比重を有する高分子物質であることが好ましいが、具体的に、ポリテトラフルオロエチレン(PTFE;商標名:テフロン(登録商標))、ポリエチレン、ポリメチルメタクリレート(PMMA)、ポリアクリロニトリル(PAN)、ポリエチレンテレフタレート(PET)及びシリコーンなどを用いることが好ましく、テフロン(登録商標)を用いることが最も好ましい。   In addition, the material of the first member (15) and the second member (16) is preferably a polymer material that is excellent in biocompatibility and has a specific gravity that does not float on the medium during fluid culture. Specifically, it is preferable to use polytetrafluoroethylene (PTFE; trade name: Teflon (registered trademark)), polyethylene, polymethyl methacrylate (PMMA), polyacrylonitrile (PAN), polyethylene terephthalate (PET), silicone, and the like. Most preferably, Teflon (registered trademark) is used.

本発明による細胞培養用膜の支持装置は培養する組織及び培養基の大きさによって任意に大きさを調節して製造され得るが、組織の大きさ及び膜を張り切った状態で支持できることなどを考慮して円型に製造する場合には、直径が10mm〜150mmであることが好ましい。   The apparatus for supporting a membrane for cell culture according to the present invention can be manufactured by adjusting the size arbitrarily according to the size of the tissue to be cultured and the culture medium. However, considering that the size of the tissue and the membrane can be supported in a stretched state, etc. When manufacturing in a circular shape, the diameter is preferably 10 mm to 150 mm.

本発明による支持装置に固定され得る膜としては一般的に組織工学の技術分野で細胞培養用膜に用いられ得るものであれば特別な限定なしに用いられ得るが、羊膜を用いることが最も好ましく、羊膜以外にも分解性人工基質として天然材料であるコラーゲン膜、ゼラチン膜、キチン膜、キトサン膜、アルジネート膜、ヒアルロン酸膜とこれらの誘導体を用いて製造した膜が用いられ得、合成基質としてPLGA(poly(D,L-lactic-co-glycolic acid))膜、PGA(polyglycolic acid)膜、PLA(poly(lactic acid))膜などが用いられ得る。前記膜は治療のために培養された細胞からなる組織を移植してから除去しなければならない煩わしさを考慮すると、生体吸収材料を用いることが好ましく、特に、分解生成物が炎症反応を起こさない生体親和性の高いものが好ましい。   The membrane that can be fixed to the supporting device according to the present invention can be used without particular limitation as long as it can be used for membranes for cell culture in the technical field of tissue engineering, but it is most preferable to use amniotic membrane. In addition to amniotic membranes, natural materials such as collagen membranes, gelatin membranes, chitin membranes, chitosan membranes, alginate membranes, hyaluronic acid membranes and their derivatives can be used as synthetic substrates. A PLGA (poly (D, L-lactic-co-glycolic acid)) film, a PGA (polyglycolic acid) film, a PLA (poly (lactic acid)) film, or the like may be used. The membrane is preferably a bioabsorbable material, taking into account the inconvenience that must be removed after transplanting tissue consisting of cultured cells for treatment, and in particular, the degradation product does not cause an inflammatory reaction. Those having high biocompatibility are preferred.

また、前記本発明の第1態様による細胞培養用膜の支持装置には、図1fに示すように、第1部材(15) の突出部と第2部材(16) の受容部との間に中間輪(17)が挿入され得る。このように中間輪が挿入された本発明の第2態様による細胞培養用膜の支持装置は、特に、目を瞬きする時のような乾燥状態(目を開けている場合)と湿潤状態(目をつぶっている場合)が反復的に起る環境で角膜細胞を培養して角膜を再構成することに有用である。   In addition, the cell culture membrane support device according to the first aspect of the present invention includes, as shown in FIG. 1f, between the protruding portion of the first member (15) and the receiving portion of the second member (16). An intermediate ring (17) can be inserted. The cell culture membrane support device according to the second aspect of the present invention in which the intermediate ring is inserted in this way is particularly in a dry state (when the eyes are open) and a wet state (when the eyes are open). It is useful to reconstitute the cornea by culturing the corneal cells in an environment where the crushing occurs repeatedly.

図1gは、本発明の第2態様による装置の側面分離図であり、第1部材(15)の突出部と第2部材(16) の受容部との間に中間輪(17)が挿入される際の、細胞培養用膜の位置を示し、図1hは本発明の第2態様による細胞培養用膜の支持装置を製造し得る設計図が各部位の大きさ(気液界面:mm)と共に示されている。   FIG. 1g is a side-separated view of the device according to the second aspect of the present invention, in which an intermediate ring (17) is inserted between the protruding part of the first member (15) and the receiving part of the second member (16). FIG. 1h shows a design drawing for manufacturing the cell culture membrane support device according to the second embodiment of the present invention together with the size of each part (gas-liquid interface: mm). It is shown.

本発明の第2態様による支持装置を用いた具体的な角膜細胞の培養方法は次のようである。まず、羊膜の上皮面上に角膜上皮細胞を接種して液体培養した後、第2部材(16)を除去する。第2部材(16)を除去しても中間輪(17)と第1部材(15)によって羊膜が依然として固定された状態で存在するようになり、第1部材(15)の脚(13)が底部へ向かうように置けば、周りには羊膜の表面の周りには障壁が存在しないようになる。これは図1gにおいて第2部材(16)を除去した状態で中間輪(17)と結合された第1部材(15)を逆に覆した場合に該当する。このようにすれば、本発明の第1態様による装置において羊膜の周りに第1部材又は第2部材による壁が存在することとは異なって、羊膜の周りに壁が存在しなくなって培地が羊膜表面にさらに容易に接触できるようになる。以後、中間輪と結合された第1部材を培養容器の壁面の一方に片寄るようにした後、流動培養する。流動培養をする場合、羊膜上の角膜上皮層は培地への浸漬及び空気への露出を繰り返すことになるが、このような培養環境は角膜上皮細胞の実際の環境と類似するので、角膜上皮層を容易に再構成できる。   A specific corneal cell culture method using the support device according to the second aspect of the present invention is as follows. First, corneal epithelial cells are inoculated on the epithelial surface of the amniotic membrane and subjected to liquid culture, and then the second member (16) is removed. Even if the second member (16) is removed, the amniotic membrane is still fixed by the intermediate ring (17) and the first member (15), and the leg (13) of the first member (15) When placed toward the bottom, there will be no barrier around the surface of the amniotic membrane. This corresponds to the case where the first member (15) coupled to the intermediate wheel (17) is reversely covered with the second member (16) removed in FIG. 1g. In this way, in the apparatus according to the first aspect of the present invention, unlike the presence of a wall due to the first member or the second member around the amniotic membrane, there is no wall around the amniotic membrane, and the medium becomes amniotic membrane. The surface can be more easily contacted. Thereafter, the first member coupled to the intermediate ring is shifted to one of the wall surfaces of the culture vessel, and then fluid culture is performed. When fluid culture is performed, the corneal epithelial layer on the amniotic membrane is repeatedly immersed in the medium and exposed to air, but such a culture environment is similar to the actual environment of the corneal epithelial cells. Can be easily reconfigured.

一方、本発明は前記細胞培養用膜の支持装置を用いて、膜で目的とする細胞を培養(組織を再構成)する方法を提供する。このような方法を用いることによって、例えば角膜上皮層、単層の繊維芽細胞と角膜上皮層を再構成することができ、実際の角膜と類似の構造の角膜の部分層又は全層を再構成することができる。   On the other hand, the present invention provides a method for culturing a target cell on a membrane (reconstructing a tissue) using the cell culture membrane support apparatus. By using such a method, for example, a corneal epithelial layer, a monolayer of fibroblasts and a corneal epithelial layer can be reconstructed, and a partial layer or all layers of the cornea having a structure similar to the actual cornea can be reconstructed. can do.

本発明による支持装置に膜を固定させて皮膚、角膜、粘膜などの組織を再構成してから培養組織を移植する場合は、第1部材及び第2部材を分離して再構成された組織を移植すればよい。   When transplanting cultured tissue after reconstituting tissues such as skin, cornea, mucous membrane, etc. by fixing the membrane to the support device according to the present invention, the reconstructed tissue is separated by separating the first member and the second member. Just transplant.

本発明による装置を用いた細胞培養方法は静置培養だけでなく、傾斜振動培養(Tilting dynamic culture)のような動的培養又は流動培養を可能にして分化誘導期間を短縮させ得るだけではなく、実際組織と類似の基底層が得られるという長所があり、特に、角膜と同様に頑丈な基底膜が必要な組織構成に有利である。即ち、動的培養方法は拡散による培地栄養分を供給する静置培養より羊膜上の細胞に新鮮な培地内の栄養分供給を円滑にして頑丈な基底層と短時間で目的とする細胞層が得られるという長所がある。   The cell culture method using the apparatus according to the present invention not only allows stationary culture, but also enables dynamic culture such as tilting dynamic culture or fluid culture to shorten the differentiation induction period, In fact, it has an advantage that a basement layer similar to that of a tissue can be obtained, and is particularly advantageous for a tissue structure that requires a strong basement membrane like the cornea. That is, in the dynamic culture method, a stable basal layer and a desired cell layer can be obtained in a short time by smoothly supplying nutrients in fresh medium to cells on the amniotic membrane, compared to stationary culture that supplies medium nutrients by diffusion. There is an advantage.

図7は、本発明による装置を用いた流動培養方法の模式図を示す。図7において攪拌装置を、羊膜を固定した支持装置が動かないほどに遅い速度で動かせば、羊膜下の培地が動きながら羊膜上の細胞に栄養分を円滑に供給できるようになる。そのため、拡散によって培地が羊膜に供給される既存の静置培養より円滑に培地供給を行うことができる。   FIG. 7 shows a schematic diagram of a fluid culture method using the apparatus according to the present invention. In FIG. 7, if the stirring device is moved at such a slow speed that the supporting device to which the amniotic membrane is fixed does not move, the nutrient medium can be smoothly supplied to the cells on the amniotic membrane while the medium under the amniotic membrane moves. Therefore, the medium can be supplied more smoothly than the existing stationary culture in which the medium is supplied to the amniotic membrane by diffusion.

具体的な流動培養条件は、培養する細胞の種類によって異なるが、支持装置が動かない程度である6〜10rpmの速度で3日〜12日間培養することが好ましい。   Although the specific fluid culture conditions vary depending on the type of cells to be cultured, it is preferable to perform culture for 3 to 12 days at a speed of 6 to 10 rpm that does not move the support device.

さらに、本発明の細胞培養方法を用いることによって基底膜として用いられ得る羊膜やコラーゲン膜などを支持して上皮細胞を培養、分化させることによって培養し難い上皮細胞の毒性モデルを作り得るだけではなく、実際の角膜と類似する全層角膜を再構成することができる。   Furthermore, by using the cell culture method of the present invention, it is possible not only to create an epithelial cell toxicity model that is difficult to culture by culturing and differentiating epithelial cells in support of an amnion or a collagen membrane that can be used as a basement membrane. A full-thickness cornea similar to the actual cornea can be reconstructed.

本発明の一実施例では前記装置を用いて羊膜の間質面(stromal side)に単層の角膜繊維芽細胞を培養し、羊膜の上皮面(epithelial side)には角膜上皮層を再構成した。その結果、図12のBに示すように、羊膜上に角膜上皮層がよく形成されていることが分かり、透明な角膜上皮層が得られることが確認できる。また、本発明の支持装置は羊膜だけでなくコラーゲン膜の支持(固定)にも有用であることが確認できる(図14参照)。   In one embodiment of the present invention, a single layer of corneal fibroblasts was cultured on the stroma side of the amniotic membrane using the above device, and the corneal epithelial layer was reconstructed on the epithelial side of the amniotic membrane. . As a result, as shown in FIG. 12B, it can be seen that the corneal epithelial layer is well formed on the amniotic membrane, and it can be confirmed that a transparent corneal epithelial layer is obtained. Further, it can be confirmed that the supporting device of the present invention is useful not only for the amniotic membrane but also for supporting (fixing) the collagen membrane (see FIG. 14).

以下、本発明を下記実施例によってより詳しく説明する。但し、下記実施例は本発明を例示するためのものであり、本発明の範囲はこれらの実施例によって限定されない。   Hereinafter, the present invention will be described in more detail with reference to the following examples. However, the following examples are for illustrating the present invention, and the scope of the present invention is not limited by these examples.

<実施例1>角膜細胞培養用膜の支持装置の製造
角膜(cornea)を実際組織と類似する形式に製造することにおいて、角膜細胞培養の基底膜として用いられる羊膜を支持できる角膜細胞培養用の羊膜支持装置を製造した。テフロン(登録商標)(TEFLON商品名)を材質とし、角膜の大きさと培養の容易性を考慮して円型に製造した。前記支持装置の第1部材及び第2部材の内径は角膜の直径(平均:10mm、全層角膜移植の場合は中間の7mm程度の直径の角膜をパンチングして移植)を考慮して14mmとし、第1部材と第2部材との間に羊膜を固定するために外径は22mm(中間輪を第1部材と第2部材との間に挿入する場合には26mm)とした。前記支持装置を製造できる設計図を各部位の大きさ(気液界面:mm)と共に図1e及び図1hに示す。気液界面の培養を行うために脚を設け、培地の流動のために脚を3つ備えておき、脚の高さは2mmとした。第1部材と第2部材とが組立てられた支持装置は市販の培養容器を用いるために高さを9mmとした。
<Example 1> Manufacture of a support device for a corneal cell culture membrane For manufacturing a corneal cell cornea in a format similar to an actual tissue, the corneal cell culture can be used to support an amniotic membrane used as a basement membrane for corneal cell culture. An amnion support device was manufactured. Teflon (registered trademark) (trade name) was used as a material, and was manufactured in a circular shape in consideration of the size of the cornea and the ease of culture. The inner diameter of the first member and the second member of the support device is set to 14 mm in consideration of the diameter of the cornea (average: 10 mm, in the case of a full-layer cornea transplant, punching an intermediate cornea having a diameter of about 7 mm) In order to fix the amniotic membrane between the first member and the second member, the outer diameter was 22 mm (26 mm when the intermediate ring was inserted between the first member and the second member). Design drawings for manufacturing the support device are shown in FIGS. 1e and 1h together with the size of each part (gas-liquid interface: mm). Legs were provided for culturing the gas-liquid interface, three legs were provided for the flow of the medium, and the leg height was 2 mm. The support device in which the first member and the second member are assembled has a height of 9 mm in order to use a commercially available culture vessel.

<試験例>角膜細胞培養用膜の支持装置を用いた細胞培養
<試験例1>羊膜の用意
角膜細胞を培養するための膜として羊膜を用いた。羊膜は、血清検査上B型及びC型肝炎、ヒト免疫不全ウイルス(HIV)抗体、性病研究所(VDRL)実験において全て陰性であり、疾患のない健康な産母より帝王切開によって得られた胎盤を生理食塩水で洗浄した後、無菌環境で行う方法で分離した(Jerzy et al., Ann. of Trans., 4:85-90 (1999))。この分離した羊膜は0.3%オフロキサシン(ofloxacin)を含むリン酸緩衝溶液(PBS)で3〜4回洗浄した後、ニトロセルロースメンブラン(NC, Osmonics, U.S.A)に付着させた。
<Test example> Cell culture using corneal cell culture membrane support device <Test example 1> Preparation of amniotic membrane Amniotic membrane was used as a membrane for culturing corneal cells. The amniotic membrane is negative in serum tests for hepatitis B and C, human immunodeficiency virus (HIV) antibody, laboratory for sex diseases (VDRL), and placenta obtained by caesarean section from a healthy mother without disease Was washed with physiological saline and then separated by a method performed in an aseptic environment (Jerzy et al., Ann. Of Trans., 4: 85-90 (1999)). The separated amniotic membrane was washed 3 to 4 times with a phosphate buffer solution (PBS) containing 0.3% ofloxacin and then attached to a nitrocellulose membrane (NC, Osmonics, USA).

<1−1>冷凍保存羊膜の用意
ニトロセルロースメンブラン(NC, Osmonics, U.S.A)に付着させた羊膜を2cm×2cmに切ってDMEM(Dulbecco's modified essential medium)とグリセロール(Sigma, U.S.A)とを1:1の比率で混合した羊膜保存溶液に入れて−80℃で保管した。培養のためにまず冷凍保存羊膜を迅速に解凍した。解凍させた羊膜をPBSで3回洗浄した後、0.05%トリプシン(Sigma, T-4799, U.S.A)/0.02%エチレンジアミンテトラアセト酸(Gibco BRL, Cat. No. 11266-012, U.S.A)で37℃で30分間処理した後、セルスクレーパー(Cell Scraper; Nunc, 179693, U.S.A)で羊膜上皮細胞を除去した。
<1-1> Preparation of cryopreserved amniotic membrane The amniotic membrane attached to the nitrocellulose membrane (NC, Osmonics, USA) was cut into 2 cm × 2 cm and DMEM (Dulbecco's modified essential medium) and glycerol (Sigma, USA) were 1: It was stored at −80 ° C. in an amniotic membrane preservation solution mixed at a ratio of 1. For culturing, the cryopreserved amniotic membrane was first quickly thawed. The thawed amnion was washed 3 times with PBS and then 0.05% trypsin (Sigma, T-4799, USA) /0.02% ethylenediaminetetraacetic acid (Gibco BRL, Cat. No. 11266-012, USA) After treatment at 37 ° C. for 30 minutes, amniotic epithelial cells were removed with a cell scraper (Cell Scraper; Nunc, 179693, USA).

羊膜上皮細胞は隙間なく羊膜の表面を不規則的に被っており、このような不規則な羊膜の表面は角膜上皮細胞の付着面を不規則にすることによって羊膜上で他の組織の上皮細胞培養に妨害になるので、平らな培養表面を提供するためには羊膜上皮細胞を除去することが好ましい。   Amniotic epithelial cells randomly cover the surface of the amniotic membrane without any gaps, and the surface of such an irregular amniotic membrane makes epithelial cells of other tissues on the amniotic membrane by making the corneal epithelial cell attachment surface irregular. It is preferable to remove amniotic epithelial cells in order to provide a flat culture surface because it interferes with the culture.

羊膜上皮細胞を除去した羊膜をさらにPBSで3〜4回洗浄した後、前記実施例1で製造した支持装置に固定させて培養に用いた。   The amniotic membrane from which the amniotic epithelial cells were removed was further washed 3 to 4 times with PBS, and then fixed to the supporting device produced in Example 1 and used for culture.

<1−2>凍結乾燥羊膜の用意
予め洗浄した羊膜を0.05%トリプシン(Sigma, T-4799, U.S.A)/0.02%エチレンジアミンテトラアセト酸(Gibco BRL, Cat. No. 11266-012, U.S.A)で37℃で30分間処理した後、セルスクレーパー(Nunc, 179693, U.S.A)で羊膜上皮細胞を除去した。羊膜上皮細胞が除去された羊膜をさらにPBSで3〜4回洗浄した。この洗浄した羊膜を80℃で24時間凍結後、−80℃で48時間凍結乾燥(FREEZE DRY SYSTEM, SAMWON, SFDSM06, KOREA)した。凍結乾燥した羊膜を前記実施例1で製造した支持装置に固定させた後、滅菌(25kGy、グリーンピア、韓国)して培養に用いた。
<1-2> Preparation of freeze-dried amniotic membrane A previously washed amniotic membrane was treated with 0.05% trypsin (Sigma, T-4799, USA) /0.02% ethylenediaminetetraacetic acid (Gibco BRL, Cat. No. 11266-012, USA) for 30 minutes at 37 ° C., and amniotic epithelial cells were removed with a cell scraper (Nunc, 179693, USA). The amniotic membrane from which the amniotic epithelial cells were removed was further washed 3 to 4 times with PBS. The washed amniotic membrane was frozen at 80 ° C. for 24 hours and then lyophilized at −80 ° C. for 48 hours (FREEZE DRY SYSTEM, SAMWON, SFDSM06, KOREA). The lyophilized amniotic membrane was fixed on the support device manufactured in Example 1 and then sterilized (25 kGy, Green Pier, Korea) and used for culture.

<試験例2>コラーゲン膜の用意
0.3%コラーゲン溶液(BioLand Ltd., Korea)でコラーゲン膜を製造した。まず、目的とするコラーゲン膜の形態と大きさを考慮して円形又は多角形の容器に2mmの高さになるようにコラーゲン溶液を分株し、80℃で24時間凍結後、−80℃で48時間凍結乾燥してコラーゲンスポンジ(collagen sponge)を製造し、凍結乾燥したコラーゲンスポンジを0.3%コラーゲン溶液に少し濡らして平らな容器に置き、4℃で乾燥してコラーゲン膜を製造した。架橋結合の程度によってコラーゲン膜の分解速度を調節できる。このように製造されたコラーゲン膜を前記実施例1で製造した支持装置に固定した後、滅菌(25kGy、グリーンピア、韓国)して培養に用いた。
<Test Example 2> Preparation of collagen membrane A collagen membrane was produced with a 0.3% collagen solution (BioLand Ltd., Korea). First, taking into consideration the shape and size of the target collagen membrane, the collagen solution is divided into a circular or polygonal container so as to have a height of 2 mm, frozen at 80 ° C. for 24 hours, and then at −80 ° C. A collagen sponge was produced by freeze-drying for 48 hours, and the freeze-dried collagen sponge was slightly wetted with a 0.3% collagen solution, placed in a flat container, and dried at 4 ° C. to produce a collagen membrane. The degradation rate of the collagen membrane can be adjusted by the degree of crosslinking. The collagen membrane thus produced was fixed on the support device produced in Example 1, and then sterilized (25 kGy, Green Pier, Korea) and used for culture.

<試験例3>角膜繊維芽細胞、角膜上皮細胞、角膜内皮細胞の一次培養
文献(Soverin Karmiol, Methods of Tissue Engineering, Chapeter 2(Cell isolation and selection)、20頁、Academic Press, 2002)に記述されている組織付着法(Explant culture)の方法によって角膜繊維芽細胞及び角膜上皮細胞、角膜内皮細胞を一次培養した。
<Test Example 3> Primary culture of corneal fibroblasts, corneal epithelial cells, corneal endothelial cells (Soverin Karmiol, Methods of Tissue Engineering, Chapeter 2 (Cell isolation and selection), page 20, Academic Press, 2002) Corneal fibroblasts, corneal epithelial cells, and corneal endothelial cells were primarily cultured by the method of explant culture.

具体的な一次培養方法は次の通りである。まず、手術器具を用いてウサギの眼球から角鞏膜切片(cornealscleral button)を得た。前記角鞏膜切片から結膜を完全に除去した後、角膜と鞏膜がそれぞれ1mmが含まれた輪部(limbus)を得た後、残った中央角膜を手術用メスを用いて間質部位を中心に上皮細胞のある層と内皮細胞のある層に分離した。このように分離された三部分の組織から角膜の三種類の細胞を組織付着法を通じて得られた。角膜上皮細胞、角膜繊維芽細胞、角膜内皮細胞をそれぞれ輪部、上皮細胞と角膜間質層を一部含む組織、内皮層と角膜間質層を一部含む組織から得られた。それぞれの組織を22mmの大きさに切った。角膜上皮細胞は空気と接触している輪部部位を培養容器の方向にして付着させて得られ、角膜繊維芽細胞は上皮細胞と間質層を一部含む組織を、間質層を容器の方向にして付着させて得られた。また角膜内皮細胞は内皮細胞を容器の方向にして付着させて得られた。付着させた組織は組織が完全に乾燥しないように培養培地を少量入れてひと晩培養した。翌日培地を添加し、3日に一回ずつ培地を入れ替えながら約7日〜10日間培養した。付着させた組織から細胞が組織周辺に広がって培養されて一次細胞が得られた。角膜上皮細胞の培養培地はHCGS(Human corneal growth supplement; Cascade Biologics, U.S.A.)と0.06mM CaClを加えたEpiLife(Cascade Biologics, U.S.A))を用いた。HCGSにはヒドロコーチゾン(hydrocortisone) 0.18μg/ml、トランスフェリン(transferrin) 5μg/ml、ウシ脳下垂体抽出物(bovine pituitary extract; BPE) 0.2%v/v及びマウス上皮成長因子(mEGF)1μg/ml含有させた。 The specific primary culture method is as follows. First, a corneal scleral button was obtained from a rabbit eyeball using a surgical instrument. After complete removal of the conjunctiva from the keratoconus, the cornea and limbus were each obtained with a limbus containing 1 mm, and the remaining central cornea was centered on the stromal site using a scalpel. Separated into a layer with epithelial cells and a layer with endothelial cells. Three types of cells of the cornea were obtained through the tissue attachment method from the three parts of the tissue thus separated. Corneal epithelial cells, corneal fibroblasts, and corneal endothelial cells were obtained from a limbal region, a tissue partially including an epithelial cell and a corneal stromal layer, and a tissue partially including an endothelial layer and a corneal stromal layer, respectively. Each tissue was cut to a size of 22 mm. Corneal epithelial cells are obtained by attaching the limbal part in contact with air in the direction of the culture container, and corneal fibroblasts are tissues that partially contain epithelial cells and stromal layers, while stromal layers are placed in the container. It was obtained by attaching in the direction. Corneal endothelial cells were obtained by attaching endothelial cells in the direction of the container. The attached tissue was cultured overnight with a small amount of culture medium so that the tissue was not completely dried. The medium was added the next day, and cultured for about 7 days to 10 days while changing the medium once every three days. From the attached tissue, cells were spread around the tissue and cultured to obtain primary cells. As a culture medium for corneal epithelial cells, HCGS (Human corneal growth supplement; Cascade Biologics, USA) and EpiLife (Cascade Biologics, USA) supplemented with 0.06 mM CaCl 2 were used. HCGS includes hydrocortisone 0.18 μg / ml, transferrin 5 μg / ml, bovine pituitary extract (BPE) 0.2% v / v and mouse epidermal growth factor (mEGF) 1 μg / ml was contained.

角膜繊維芽細胞の培養培地は牛胎児血清(FBS; GIBCO, U.S.A.)が10%加えられたDMEM培地(Dulbecco's modified Eagle's medium; GIBCO, U.S.A.)を用い、角膜内皮細胞培養培地はOpti−MEM培地(Opti minimal essential medium; GIBCO)にFBS8%、 EGF(Sigma, U.S.A.)10ng/ml、神経成長因子(NGF; R&D, U.S.A.)20μg/ml、塩基性繊維芽細胞成長因子(bFGF; Sigma, U.S.A.)10ng/ml、RPMIビタミン混合物(RPMI vitamin mixer; Sigma, U.S.A.)1%v/v、アスコルビン酸(Sigma, U.S.A.)5μg/ml、昆虫脂質(insect lipid; Sigma, U.S.A.)0.2mg/ml、 CaCl2(GIBCO) 0.2mg/ml、CaCl2(GIBCO)0.2mg/ml及びコンドロイチンスルファート(chondrotin sulfate; Sigma, U.S.A.)0.08%を添加した培地を用いた。 The culture medium of corneal fibroblasts is DMEM medium (Dulbecco's modified Eagle's medium; GIBCO, USA) supplemented with 10% fetal bovine serum (FBS; GIBCO, USA). The corneal endothelial cell culture medium is Opti-MEM medium ( Optimal essential medium (GIBCO), FBS 8%, EGF (Sigma, USA) 10 ng / ml, nerve growth factor (NGF; R & D, USA) 20 μg / ml, basic fibroblast growth factor (bFGF; Sigma, USA) 10 ng / Ml, RPMI vitamin mixer (Sigma, USA) 1% v / v, ascorbic acid (Sigma, USA) 5 μg / ml, insect lipid (Sigma, USA) 0.2 mg / ml, CaCl 2 A medium supplemented with 0.2 mg / ml of (GIBCO), 0.2 mg / ml of CaCl 2 (GIBCO) and 0.08% chondrotin sulfate (Sigma, USA) was used.

<試験例4>3世代細胞を用いた角膜上皮層の再構成
培養容器で組織付着法で一次細胞を得た。この一次細胞の量によって1:2又は1:3で継代培養して5〜7日後2世代細胞を得、約1:4で継代培養して4〜6日後3世代細胞を得た。このようにして得た3世代細胞を角膜上皮層の再構成に用いた。
羊膜上に3世代角膜上皮細胞5×10個を接種した。1〜2日間液体培養した後、6日間気液界面培養して角膜上皮層を再構成した。培地はHCGS(Human corneal growth supplement)を添加したEpiLife(Cascade Biologics, U.S.A)を用いた。
<Test Example 4> Reconstitution of corneal epithelial layer using third generation cells Primary cells were obtained by a tissue adhesion method in a culture vessel. Depending on the amount of primary cells, the cells were subcultured 1: 2 or 1: 3 to obtain 2 generation cells after 5 to 7 days, and subcultured at about 1: 4 to obtain 3 generation cells after 4 to 6 days. The 3rd generation cells thus obtained were used for reconstitution of the corneal epithelial layer.
5 × 10 5 3 generation corneal epithelial cells were inoculated on the amniotic membrane. After liquid culture for 1-2 days, the corneal epithelial layer was reconstituted by gas-liquid interface culture for 6 days. EpiLife (Cascade Biologics, USA) supplemented with HCGS (Human corneal growth supplement) was used as the medium.

再構成された角膜上皮層に対して下記<試験例9>の組織学検査を行って、その結果を図3〜図6に示す。
図3は、再構成された角膜上皮層のH/E染色写真で、3日間気液界面培養を行った上皮層(A)では接種した細胞が安定化されて2〜3層の上皮細胞がよく付着していることが確認でき、6日間気液界面培養を行った上皮層(B及びC)は実際の角膜の上皮層と類似する形態が確認できた。
The reconstructed corneal epithelial layer was subjected to the following <Test Example 9> histological examination, and the results are shown in FIGS.
FIG. 3 is an H / E-stained photograph of the reconstructed corneal epithelial layer. In the epithelial layer (A) that has been subjected to the gas-liquid interface culture for 3 days, the inoculated cells are stabilized and two to three layers of epithelial cells are formed. It was confirmed that the cells were well attached, and the epithelial layers (B and C) subjected to the gas-liquid interface culture for 6 days were confirmed to have a form similar to the actual epithelial layer of the cornea.

一方、図4は再構成された角膜上皮層のAE5で免疫組織化学染色した写真である。凍結乾燥羊膜でそれぞれ3日、6日間気液界面培養したもの(A及びB)と冷凍保存羊膜で6日間気液界面培養した上皮層(C)の表面細胞(superficial cell)は、角膜上皮層の分化がよく行われて角膜の表面細胞と類似する形態が確認できた。
また、図5は、再構成された角膜上皮層をPCNA(proliferating cell nuclear antigen)で免疫組織化学染色した写真で、実際の角膜(D)から基底層付近に増殖能力の活発な細胞が観察されたように、羊膜で培養された角膜上皮細胞(A〜C)も実際の角膜上皮細胞のように増殖能力が活発であることが確認できる。
On the other hand, FIG. 4 is a photograph obtained by immunohistochemical staining of the reconstructed corneal epithelial layer with AE5. The surface cells (superficial cells) of the epithelial layer (C) cultured on the air-liquid interface for 3 days and 6 days on freeze-dried amniotic membrane (A and B) and the cryo-preserved amniotic membrane on the air-liquid interface for 6 days are the corneal epithelial layer. Differentiation was often performed, and a morphology similar to that of corneal surface cells was confirmed.
FIG. 5 is a photograph of the reconstructed corneal epithelial layer immunohistochemically stained with PCNA (proliferating cell nuclear antigen), in which active proliferating cells are observed near the basal layer from the actual cornea (D). As described above, it can be confirmed that the corneal epithelial cells (A to C) cultured in the amniotic membrane have active proliferation ability like the actual corneal epithelial cells.

さらに、図6は、再構成された角膜上皮層の透過電子顕微鏡(TEM)の写真で、冷凍保存羊膜(A)と凍結乾燥羊膜(D)上に角膜上皮層がよく付着していることが確認でき、ヘミデスモゾーム(hemidesmosome)の形成から羊膜に角膜上皮細胞がよく付着していることが分かるだけではなく(B及びE)、デスモゾームの形成から細胞の間の交流が円滑に行われることが確認できる(C及びF)。   Further, FIG. 6 is a transmission electron microscope (TEM) photograph of the reconstructed corneal epithelial layer, which shows that the corneal epithelial layer is well attached on the cryopreserved amniotic membrane (A) and the freeze-dried amniotic membrane (D). It can be confirmed that the formation of hemidesmosome not only shows that the corneal epithelial cells are well attached to the amniotic membrane (B and E), but also that the exchange between the cells is facilitated by the formation of desmosomes. Can be confirmed (C and F).

<試験例5>流動培養方法を用いた角膜上皮層の再構成
羊膜上に3世代と解凍した4世代の角膜上皮細胞5×10個を接種した。解凍した4世代の細胞は、3世代の細胞をEpiLife、血清、凍結細胞保護剤(Dimethyl sulfoxide(DMSO))をそれぞれ8:1:1で混合した後、1×10cells/mlの濃度で凍結保存した細胞を迅速に解凍した後、増殖させて得られた。1〜2日液体培養した後、9日間流動培養、例えば、傾斜振動培養(Tilting dynamic culture, RPM:6)を用いて気液界面培養して角膜上皮層を再構成した。培地はHCGSを添加したEpiLife(Cascade Biologics, U.S.A)を用いた。
<Test Example 5> Reconstitution of corneal epithelial layer using flow culture method 5 × 10 5 corneal epithelial cells of 3 generations and 4 th generation of thawing were inoculated on the amniotic membrane. Thawed 4th generation cells were mixed with EpiLife, serum, and frozen cytoprotective agent (Dimethyl sulfoxide (DMSO)) at 8: 1: 1 respectively at a concentration of 1 × 10 6 cells / ml. Cryopreserved cells were rapidly thawed and then expanded. After liquid culture for 1-2 days, the corneal epithelial layer was reconstituted by gas-liquid interface culture using 9-day fluid culture, for example, tilting dynamic culture (RP: 6). As the medium, EpiLife (Cascade Biologics, USA) supplemented with HCGS was used.

再構成された角膜上皮層に対して下記<試験例9>の組織学検査を行って、その結果を図8〜図10に示す。   The reconstructed corneal epithelial layer was subjected to the following <Test Example 9> histological examination, and the results are shown in FIGS.

図8は、流動培養方法を用いて羊膜上でそれぞれ9日(A、B)、6日(C、D)間再構成した角膜上皮層のH/E染色写真である。図8のAとBとを比較してみる際、流動培養方法が静置培養に比べ、同一の期間中により多い角膜上皮層に培養されることが分かる。これは、流動培養が静置培養より羊膜上の角膜上皮細胞に培地の栄養分と酸素を円滑に供給して上皮細胞の成長と分化を促進するためである。図9のCとDとの比較によってこのような傾向が分かる。図9のCとDは解凍した4世代の角膜上皮細胞にて羊膜上で角膜上皮層をそれぞれ静置培養と流動培養で再構成したものを示す。通常、細胞を液体窒素で保存してから解凍する場合、貯蔵と解凍の方法によって異なるが、細胞が損傷を被るようになり、このように損傷を被った細胞に栄養分を充分に供給できる流動培養法を利用すれば、図9のDのように角膜上皮層と同様な上皮層を再構成できる。静置培養では角膜上皮層を殆ど再構成できなかったが(図9のC参照)、流動培養を通じては実際の角膜の基底層と類似する角膜上皮層が得られた。   FIG. 8 is an H / E-stained photograph of the corneal epithelial layer reconstructed on the amniotic membrane for 9 days (A, B) and 6 days (C, D), respectively, using the flow culture method. When comparing A and B in FIG. 8, it can be seen that the flow culture method is cultured in more corneal epithelial layers during the same period than the stationary culture. This is because fluid culture smoothly supplies nutrients and oxygen of the medium to corneal epithelial cells on the amniotic membrane than stationary culture to promote the growth and differentiation of epithelial cells. Such a tendency can be seen by comparing C and D in FIG. FIGS. 9C and 9D show thawing four-generation corneal epithelial cells obtained by reconstituting the corneal epithelial layer on the amniotic membrane by stationary culture and fluid culture, respectively. Usually, when thawing after storing cells in liquid nitrogen, depending on the storage and thawing method, cells become damaged, and fluid culture that can sufficiently supply nutrients to such damaged cells If the method is used, an epithelial layer similar to the corneal epithelial layer can be reconstructed as shown in FIG. 9D. Although the corneal epithelial layer could hardly be reconstructed by static culture (see FIG. 9C), a corneal epithelial layer similar to the basal layer of the actual cornea was obtained through fluid culture.

また、図10は、流動培養方法を用いて羊膜上で再構成された角膜上皮層のPCNA免疫組織化学染色写真で、図5のBと比べて見れば、増殖能力に優れた能力を有する細胞が流動培養で得た上皮層の基底層に存在することが分かる。   FIG. 10 is a PCNA immunohistochemically stained photograph of the corneal epithelial layer reconstituted on the amniotic membrane using the flow culture method. Compared with FIG. 5B, the cells have excellent proliferation ability. Is present in the basal layer of the epithelial layer obtained by fluid culture.

<試験例6>羊膜の間質面と上皮面に単層の角膜繊維芽細胞と角膜上皮層の再構成
凍結乾燥羊膜の間質面(stromal side)に細胞を培養する場合は、羊膜のスポンジ層(Spongy layer)と母細胞層(Fibroblast layer)を除去してから培養しなければならない。羊膜の層は上皮面(epithelial side)から上皮層、基底膜、緻密層(Condense layer)、母細胞層、スポンジ層からなる。特に、間質面のスポンジ層は絨毛膜と付着される部位であって粘液性であるため、細胞が付着できずに球形の状態で途中壊死する。そのため羊膜の間質面に培養する際、羊膜の処理が重要である。従って、スポンジ層及び母細胞層が除去された凍結乾燥羊膜の間質面に角膜繊維芽細胞2×10個を接種した後、5日間培養した。5日間培養した後、羊膜を覆して上皮面に5×10個の上皮細胞を接種し、2日間培養した後、6日間気液界面培養した。
<Test Example 6> Reconstitution of monolayer corneal fibroblasts and corneal epithelial layer on the stromal and epithelial surfaces of the amniotic membrane When culturing cells on the stromal side of the lyophilized amnion, an amnion sponge It is necessary to culture after removing the layer (Spongy layer) and the mother cell layer (Fibroblast layer). The amniotic membrane layer is composed of an epithelial side to an epithelial layer, a basement membrane, a dense layer, a mother cell layer, and a sponge layer. In particular, since the sponge layer on the interstitial surface is a site that adheres to the chorion and is mucous, cells cannot adhere to it and are necrotized halfway in a spherical state. Therefore, when culturing on the interstitial surface of the amniotic membrane, the treatment of the amniotic membrane is important. Therefore, 2 × 10 5 corneal fibroblasts were inoculated on the stromal surface of the lyophilized amniotic membrane from which the sponge layer and mother cell layer had been removed, and then cultured for 5 days. After culturing for 5 days, the amnion was covered and 5 × 10 5 epithelial cells were inoculated on the epithelial surface, cultured for 2 days, and then cultured for 6 days.

培養した後<試験例9>の組織学検査を行って、その結果を図11及び図13に示す。
図11は、羊膜の間質面に角膜繊維芽細胞を単層培養し、上皮面には角膜上皮層を再構成したH/E染色写真で、Aは静置培養、Bは流動培養で培養した写真である。本発明による支持装置によって羊膜の両面に二つの角膜細胞を容易に培養し得ることが分かる。
After culturing, the histological examination of <Test Example 9> was performed, and the results are shown in FIGS.
FIG. 11 is a H / E-stained photograph in which corneal fibroblasts are monolayer cultured on the interstitial surface of the amniotic membrane and the corneal epithelial layer is reconstructed on the epithelial surface, A is stationary culture, and B is fluid culture. It is a photograph. It can be seen that two corneal cells can be easily cultured on both sides of the amniotic membrane by the support device according to the present invention.

一方、図13は、羊膜の間質面に角膜繊維芽細胞を単層培養し、上皮面には角膜上皮層を再構成したTEM写真で、細胞間のデスモゾーム(A及びC)と羊膜と角膜上皮細胞間のヘミデスモゾーム(B及びD)が観察できるため、これから再構成された角膜上皮層は細胞と細胞間の結合及び羊膜と角膜上皮細胞間の結合が非常によく行われていることが分かる。   On the other hand, FIG. 13 is a TEM photograph in which corneal fibroblasts are monolayer cultured on the interstitial surface of the amniotic membrane and the corneal epithelial layer is reconstructed on the epithelial surface. Since hemidesmosomes (B and D) between epithelial cells can be observed, the reconstituted corneal epithelial layer is very well connected between cells and between amnion and corneal epithelial cells. I understand.

<試験例7>コラーゲン膜を用いた皮膚表皮層の再構成
角質形成細胞の一次培養には酵素分解法(enzymatic digestion)を利用した。表皮組織(foreskin)をそれぞれカルシウムアセテート緩衝溶液(130mM NaCl、10 mM カルシウムアセテート、20mM HEPES、pH7.2)に溶かしたコラゲナーゼ(collagenase)溶液3mg(1000U)/mLとPBSに溶かしたディスパーゼ(dispase)溶液1mg(1.5U)/mL、及び0.05%トリプシン酵素溶液を用いた。角質形成細胞培養には角質形成細胞の分化と線維芽細胞の汚染を防ぐためにヒドロコーチゾン、インシュリン、トリヨードチロニン(triiodothyronine)など角質形成細胞の特異的成長ホルモン(keratinocyte specific growth hormone)を加えた、低いCa2+濃度のK−SFM(serum-free keratinocyte medium, Gibco. Cat.# 320-7005PJ)にEGF(epidermal growth factor, 5.0 g/L)とBPE(bovine pituitary extract, 50 mg/L)を添加した培地を用いた。一次培養で得た角質形成細胞を1:4の2回の継代培養を通じて3世代細胞を得た。コラーゲン膜の上に3世代角質形成細胞を5×10個接種した。1〜2日間液体培養した後、7日間気液界面培養して皮膚表皮層を再構成した。再構成された皮膚表皮層に対して下記<試験例9>の組織学検査のうち、H/E染色を行ってその結果を図14に示す。図14から分かるように、コラーゲン膜上で再構成された皮膚表皮層が得られた。
<Test Example 7> Reconstruction of skin epidermis layer using collagen membrane Enzymatic digestion was used for primary culture of keratinocytes. A collagenase solution 3 mg (1000 U) / mL in which the skin tissue (foreskin) is dissolved in a calcium acetate buffer solution (130 mM NaCl, 10 mM calcium acetate, 20 mM HEPES, pH 7.2) and dispase in PBS A solution of 1 mg (1.5 U) / mL and 0.05% trypsin enzyme solution was used. In order to prevent keratinocyte differentiation and fibroblast contamination, keratinocyte specific growth hormone such as hydrocortisone, insulin, and triiodothyronine was added to the keratinocyte culture. EGF (epidermal growth factor, 5.0 g / L) and BPE (bovine pituitary extract, 50 mg / L) to K-SFM (serum-free keratinocyte medium, Gibco. Cat. # 320-7005PJ) with low Ca 2+ concentration The added medium was used. The 3rd generation cells were obtained from the keratinocytes obtained in the primary culture through two subcultures of 1: 4. 5 × 10 5 3 generation keratinocytes were inoculated on the collagen membrane. After liquid culture for 1-2 days, the skin epidermis layer was reconstituted by gas-liquid interface culture for 7 days. Of the histological examination of <Test Example 9> below, H / E staining was performed on the reconstructed skin epidermal layer, and the results are shown in FIG. As can be seen from FIG. 14, a reconstructed skin epidermis layer was obtained on the collagen membrane.

<試験例8>中間輪が挿入された支持装置に固定された羊膜における角膜上皮層の再構成
中間輪が挿入されて支持装置に固定された羊膜上皮面上に解凍した4世代の角膜上皮細胞5×10個を接種し、1〜2日間液体培養した。培地はHCGS(Human corneal growth supplement)を添加したEpiLife(Cascade Biologics, U.S.A)を用いた。その後、中間輪の挿入された支持装置より第2部材を除去し、中間輪と結合された第1部材を脚を底面に向かうようにして培養容器の壁面の一方に片寄るように位置づけ、6rpmの速度で6日間流動培養した。
<Test Example 8> Reconstruction of the corneal epithelial layer in the amniotic membrane fixed to the support device with the intermediate ring inserted Four generations of corneal epithelial cells thawed on the amniotic epithelial surface with the intermediate ring inserted and fixed to the support device 5 × 10 5 cells were inoculated and liquid cultured for 1-2 days. EpiLife (Cascade Biologics, USA) supplemented with HCGS (Human corneal growth supplement) was used as the medium. Thereafter, the second member is removed from the support device in which the intermediate ring is inserted, and the first member coupled to the intermediate ring is positioned so as to be offset to one of the wall surfaces of the culture vessel with the legs facing the bottom surface, Fluid culture was carried out at a speed for 6 days.

再構成された角膜上皮層に対して下記<試験例9>の組織学検査のうち、H/E染色を行ってその結果を図15に示す。図8のC及びDの写真と比べても図15の角膜上皮層が実際の角膜と類似する形態で再構成されていることが確認できた。   Of the histological examination of <Test Example 9> below, H / E staining was performed on the reconstructed corneal epithelial layer, and the results are shown in FIG. It was confirmed that the corneal epithelial layer in FIG. 15 was reconstructed in a form similar to the actual cornea even when compared with the photographs in C and D in FIG.

<試験例9>組織学検査
組織学検査は組織検査学(全国臨床病理教授協議会、高麗医学、1992)と病理組織特殊染色図鑑(キム・ジュホ、シングァン出版社、1993)を参考して行った。
(1)ヘマトキシリン/エオシン染色(hematoxlyn/eosin(H/E) staining)
標本を4%ホルムアルデヒド溶液でしょりした後、パラフィンで固定したものを切断して得た切片をヘマトキシリン−エオシン染色を行った。
<Test Example 9> Histological Examination Histological examination is performed with reference to histopathology (National Council of Clinical Pathology, Korean Medicine, 1992) and pathological tissue special staining picture book (Kim Ju-ho, Singhwan Publishing Co., 1993). It was.
(1) Hematoxylin / eosin (H / E) staining
After the specimen was dripped with a 4% formaldehyde solution, a section obtained by cutting the paraffin-fixed one was stained with hematoxylin-eosin.

(2)AE5染色
標本を4%ホルムアルデヒド溶液で処理した後、パラフィンに固定したものを切断して得た切片を角膜上皮細胞の分化特異的蛋白質であるAE5で染色した。この染色を通じて再構成された角膜上皮層が正しく分化されたかを観察した。
(3)PCNA染色
標本を4%ホルムアルデヒド溶液で処理した後、パラフィンで固定したものを切断して得た切片をPCNA染色を行う。この染色を通じて増殖能のある細胞を観察した。
(2) AE5 staining A specimen obtained by treating a specimen with a 4% formaldehyde solution and then cutting a sample fixed to paraffin was stained with AE5, which is a differentiation-specific protein of corneal epithelial cells. It was observed whether the reconstructed corneal epithelial layer was correctly differentiated through this staining.
(3) PCNA staining After the specimen is treated with a 4% formaldehyde solution, a section obtained by cutting a paraffin-fixed piece is subjected to PCNA staining. Proliferating cells were observed through this staining.

(4)電子顕微鏡検査
羊膜上皮細胞を除去した羊膜と除去していない羊膜の表面と断面、再構成された角膜上皮層の断面を電子顕微鏡で観察した。4%グルタールアルデヒドと2%ホルムアルデヒドで組織を固定した後、2%オスミウムテトロキシド(osmium tetroxide)で再固定した。再固定された組織を脱水した後、コーティングして走査電子顕微鏡(Scanning Electron Microscope(SEM), JSM-35CF, Jeol, Japan)と透過電子顕微鏡(Transmission Electron Microscope(TEM), JEM-200CX, Jeol, Japan)で観察した。
(4) Electron Microscopy The surface and cross section of the amniotic membrane from which the amniotic epithelial cells were removed and the non-removed amniotic membrane, and the cross section of the reconstructed corneal epithelial layer were observed with an electron microscope. The tissue was fixed with 4% glutaraldehyde and 2% formaldehyde and then re-fixed with 2% osmium tetroxide. After dehydrating the re-fixed tissue, coating and scanning electron microscope (SEM), JSM-35CF, Jeol, Japan and transmission electron microscope (TEM), JEM-200CX, Jeol, Observed in Japan).

本発明の第1態様による細胞培養用膜の支持装置に対する斜視図(図1a)を示す。The perspective view (FIG. 1a) with respect to the support apparatus of the film | membrane for cell cultures by the 1st aspect of this invention is shown. 本発明の第1態様による細胞培養用膜の支持装置に対する側面分離図(図1b)を示す。FIG. 2 shows a side separation view (FIG. 1b) of the apparatus for supporting a membrane for cell culture according to the first embodiment of the present invention. 本発明の第1態様による細胞培養用膜の支持装置に対する平面図(図1c)を示す。The top view (FIG. 1c) with respect to the support apparatus of the film | membrane for cell cultures by the 1st aspect of this invention is shown. 本発明の第1態様による細胞培養用膜の支持装置に対する側面結合図(図1d)を示す。FIG. 2 shows a side view (FIG. 1d) of the cell culture membrane support device according to the first embodiment of the present invention. 本発明の第1態様による細胞培養用膜の支持装置に対する設計図(図1e)を示す。1 shows a design diagram (FIG. 1e) for a cell culture membrane support device according to a first embodiment of the present invention. 本発明の第2態様による細胞培養用膜の支持装置に対する斜視図(図1f)を示す。The perspective view (FIG. 1f) with respect to the support apparatus of the film | membrane for cell cultures by the 2nd aspect of this invention is shown. 本発明の第2態様による細胞培養用膜の支持装置に対する側面分離図(図1g)を示す。FIG. 3 shows a side separation view (FIG. 1g) of the cell culture membrane support device according to the second embodiment of the present invention. 本発明の第2態様による細胞培養用膜の支持装置に対する設計図(図1h)を示す。FIG. 1h shows a design diagram (FIG. 1h) for a cell culture membrane support apparatus according to a second embodiment of the present invention. 本発明の第1態様によって円型(ring type)に製造された支持装置の写真(A)であって、支持装置によって固定される膜が凍結乾燥羊膜である場合(B)と冷凍保存羊膜である場合(C)とをそれぞれ例として示す。FIG. 4 is a photograph (A) of a support device manufactured in a ring type according to the first embodiment of the present invention, where the membrane fixed by the support device is a freeze-dried amniotic membrane (B) and a frozen storage amniotic membrane. Case (C) is shown as an example. 本発明の第1態様による装置に固定された羊膜上で角膜上皮細胞を培養した後、これをヘマトキシリン/エオシン(H/E)(hematoxylin/eosin)で染色した写真を示す。 A:凍結乾燥羊膜上で気液界面培養を3日間行った B:凍結乾燥羊膜上で気液界面培養を6日間行った C:冷凍保存羊膜上で気液界面培養を6日間行った D:実際ウサギ角膜の上皮層The photograph which culture | cultivated the corneal epithelial cell on the amniotic membrane fixed to the apparatus by the 1st aspect of this invention, and dye | stained this with hematoxylin / eosin (H / E) (hematoxylin / eosin) is shown. A: Gas-liquid interface culture was performed on freeze-dried amniotic membrane for 3 days B: Gas-liquid interface culture was performed on freeze-dried amniotic membrane for 6 days C: Gas-liquid interface culture was performed on frozen storage amniotic membrane for 6 days D: The epithelial layer of the actual rabbit cornea 本発明の第1態様による装置に固定された羊膜上で角膜上皮細胞を培養した後、これを角膜上皮細胞の分化特異蛋白質であるAE5で免疫組織化学染色した写真を示す。 A:凍結乾燥羊膜上で気液界面培養を3日間行った B:凍結乾燥羊膜上で気液界面培養を6日間行った C:冷凍保存羊膜上で気液界面培養を6日間行った D:実際ウサギ角膜の上皮層The photograph which culture | cultivated the corneal epithelial cell on the amniotic membrane fixed to the apparatus by the 1st aspect of this invention, and immunostained this with AE5 which is a differentiation specific protein of a corneal epithelial cell is shown. A: Gas-liquid interface culture was performed on freeze-dried amniotic membrane for 3 days B: Gas-liquid interface culture was performed on freeze-dried amniotic membrane for 6 days C: Gas-liquid interface culture was performed on frozen storage amniotic membrane for 6 days D: The epithelial layer of the actual rabbit cornea 本発明の第1態様による装置に固定された羊膜上で角膜上皮細胞を培養した後、これをPCNA(proliferating cell nuclear antigen)で免疫組織化学染色した写真を示す。 A:凍結乾燥羊膜上で気液界面培養を3日間行った B:凍結乾燥羊膜上で気液界面培養を6日間行った C:冷凍保存羊膜上で気液界面培養を6日間行った D:実際ウサギ角膜の上皮層The photograph which culture | cultivated the corneal epithelial cell on the amniotic membrane fixed to the apparatus by the 1st aspect of this invention, and immunostained this with PCNA (proliferating cell nuclear antigen) is shown. A: Gas-liquid interface culture was performed on freeze-dried amniotic membrane for 3 days B: Gas-liquid interface culture was performed on freeze-dried amniotic membrane for 6 days C: Gas-liquid interface culture was performed on frozen storage amniotic membrane for 6 days D: The epithelial layer of the actual rabbit cornea 本発明の第1態様による装置に固定された羊膜上で角膜上皮細胞を培養した後、透過電子顕微鏡(TEM)で観察した写真である。 A:冷凍保存羊膜上で培養した角膜上皮層のTEM写真(基底層) B:冷凍保存羊膜上で培養した角膜上皮層のTEM写真(ヘミデスモゾーム) C:冷凍保存羊膜上で培養した角膜上皮層のTEM写真(デスモゾーム) D:凍結乾燥羊膜上で培養した角膜上皮層のTEM写真(基底層) E:凍結乾燥羊膜上で培養した角膜上皮層のTEM写真(ヘミデスモゾーム) F:凍結乾燥羊膜上で培養した角膜上皮層のTEM写真(デスモゾーム)It is the photograph observed after cultivating the corneal epithelial cell on the amniotic membrane fixed to the apparatus by the 1st aspect of this invention, and using the transmission electron microscope (TEM). A: TEM photograph of corneal epithelial layer cultured on cryopreserved amniotic membrane (basal layer) B: TEM photograph of corneal epithelial layer cultured on cryopreserved amniotic membrane (hemidesmosome) C: Corneal epithelial layer cultured on cryopreserved amniotic membrane TEM photograph (desmosome) D: TEM photograph of corneal epithelial layer cultured on freeze-dried amniotic membrane (basal layer) E: TEM photograph of corneal epithelial layer cultured on freeze-dried amniotic membrane (hemidesmosome) F: On freeze-dried amniotic membrane Photograph of corneal epithelial layer cultured in potato (desmosome) 本発明による装置を用いた流動培養方法の模式図である。It is a schematic diagram of the fluid culture method using the apparatus by this invention. 流動培養方法を用いて本発明の第1態様による装置に固定された羊膜上で角膜上皮細胞を培養した後、H/Eで染色した写真を示す。 A:9日間静置培養で気液界面培養した B:9日間流動培養で気液界面培養した C:解凍した細胞を用いて6日間定置培養で気液界面培養した D:解凍した細胞を用いて6日間流動培養で気液界面培養したThe photograph which dye | stained by H / E after culture | cultivating a corneal epithelial cell on the amniotic membrane fixed to the apparatus by the 1st aspect of this invention using a fluid culture method is shown. A: Gas-liquid interface culture by static culture for 9 days B: Gas-liquid interface culture by flow culture for 9 days C: Gas-liquid interface culture by stationary culture for 6 days using thawed cells D: Using thawed cells Gas-liquid interface culture in fluid culture for 6 days 流動培養方法を用いて本発明の第1態様による装置に固定された羊膜上で角膜上皮細胞を培養した後、AE5で免疫組織化学染色した写真を示す。 A:6日間流動培養で気液界面培養した B:9日間流動培養で気液界面培養したThe photograph which carried out the immunohistochemical dyeing | staining by AE5 after culture | cultivating a corneal epithelial cell on the amniotic membrane fixed to the apparatus by the 1st aspect of this invention using a fluid culture method is shown. A: Gas-liquid interface culture by fluid culture for 6 days B: Gas-liquid interface culture by fluid culture for 9 days 流動培養方法を用いて本発明の第1態様による装置に固定された羊膜上で角膜上皮細胞を培養した後、PCNAで免疫組織化学染色した写真を示す。 A:6日間流動培養で気液界面培養した B:9日間流動培養で気液界面培養したThe photograph which carried out immunohistochemical dyeing | staining by PCNA after culture | cultivating a corneal epithelial cell on the amniotic membrane fixed to the apparatus by the 1st aspect of this invention using a fluid culture method is shown. A: Gas-liquid interface culture by fluid culture for 6 days B: Gas-liquid interface culture by fluid culture for 9 days 本発明の第1態様による装置を用いて羊膜の間質面に角膜繊維芽細胞を単層培養し、上皮面には角膜上皮細胞を培養した後、H/Eで染色した写真を示す。 A:静置培養で培養した B:流動培養で培養したA photograph of corneal fibroblasts monolayer cultured on the stromal surface of the amniotic membrane using the apparatus according to the first aspect of the present invention and corneal epithelial cells cultured on the epithelial surface and then stained with H / E is shown. A: cultured by static culture B: cultured by fluid culture 本発明の第1態様による装置を用いて羊膜の間質面に角膜繊維芽細胞を単層培養し、上皮面には角膜上皮細胞を培養した後の写真を示し、培養後のデジタル写真(A)及び第1部材及び第2部材を除去した後の写真(B)を示す。Using the apparatus according to the first aspect of the present invention, corneal fibroblasts are monolayer-cultured on the stromal surface of the amniotic membrane, and the epithelial surface shows a photograph after culturing the corneal epithelial cells. ) And a photograph (B) after removing the first member and the second member. 本発明の第1態様による装置を用いて羊膜の間質面に角膜繊維芽細胞を単層培養し、上皮面には角膜上皮細胞を培養した後、TEMで観察した写真である。 A:静置培養で培養した B:流動培養で培養したIt is the photograph observed by TEM, after culturing corneal fibroblasts on the stromal surface of the amniotic membrane and culturing corneal epithelial cells on the epithelial surface using the apparatus according to the first aspect of the present invention. A: cultured by static culture B: cultured by fluid culture 本発明の第1態様による装置に固定されたコラーゲン膜上で皮膚表皮細胞を培養した後、これをH/Eで染色した写真を示す。The photograph which cultivated the skin epidermal cell on the collagen membrane fixed to the apparatus by the 1st aspect of this invention, and dye | stained this with H / E is shown. 本発明の第2態様による装置に固定された羊膜上で角膜上皮層を培養した後、これをH/Eで染色した写真を示す。The photograph which culture | cultivated the corneal epithelial layer on the amniotic membrane fixed to the apparatus by the 2nd aspect of this invention, and dye | stained this with H / E is shown.

Claims (11)

中央に貫通孔、貫通孔の側面に沿って一方の面に形成された突出部、及び他方の面に3個以上の脚を備えた第1部材;及び
中央に貫通孔、貫通孔の側面に沿って一方の面に前記第1部材の突出部を取り込むための受容部、及び他方の面に3個以上の脚を備えた第2部材を含み、
第1部材の突出部と第2部材の受容部とはその間に細胞培養用膜を固定させ得るように噛み合う、細胞培養用膜の支持装置。
A through-hole in the center, a protrusion formed on one side along the side of the through-hole, and a first member having three or more legs on the other side; and a through-hole in the center, on the side of the through-hole A receiving portion for taking in the protruding portion of the first member on one surface along the second member, and a second member having three or more legs on the other surface,
A device for supporting a cell culture membrane, wherein the protruding portion of the first member and the receiving portion of the second member mesh with each other so that the membrane for cell culture can be fixed therebetween.
前記第1部材の突出部と第2部材の受容部との間に中間輪が挿入されることを特徴とする請求項1に記載の装置。   The apparatus according to claim 1, wherein an intermediate ring is inserted between the protruding portion of the first member and the receiving portion of the second member. 前記第1部材及び第2部材は円型部材であることを特徴とする請求項1に記載の装置。   The apparatus according to claim 1, wherein the first member and the second member are circular members. 前記第1部材及び第2部材の材質がポリテトラフルオロエチレン(PTFE;商標名:テフロン(登録商標))、ポリエチレン、ポリメチルメタクリレート(PMMA)、ポリアクリロニトリル(PAN)、ポリエチレンテレフタレート(PET)及びシリコーンからなる群から選択される生体適合高分子物質であることを特徴とする請求項1に記載の装置。   The material of the first member and the second member is polytetrafluoroethylene (PTFE; trade name: Teflon (registered trademark)), polyethylene, polymethyl methacrylate (PMMA), polyacrylonitrile (PAN), polyethylene terephthalate (PET) and silicone. The device of claim 1, wherein the device is a biocompatible polymeric substance selected from the group consisting of: 前記受容部は凹溝の形態であることを特徴とする請求項1に記載の装置。   The apparatus of claim 1, wherein the receiving portion is in the form of a concave groove. 前記膜が羊膜、コラーゲン膜、ゼラチン膜、キチン膜、キトサン膜、アルジネート膜、ヒアルロン酸膜、PLGA(poly(D, L-lactic-co-glycolic acid))膜、PGA(polyglycolic acid)膜、PLA(poly(lactic acid))膜からなる群から選択されることを特徴とする請求項1に記載の装置。   The membrane is an amniotic membrane, collagen membrane, gelatin membrane, chitin membrane, chitosan membrane, alginate membrane, hyaluronic acid membrane, PLGA (poly (D, L-lactic-co-glycolic acid)) membrane, PGA (polyglycolic acid) membrane, PLA The device of claim 1, wherein the device is selected from the group consisting of (poly (lactic acid)) membranes. 請求項1〜6のいずれか一項に記載の細胞培養用膜の支持装置と前記膜とを用いて、目的とする細胞を培養する方法。   A method for culturing target cells using the support device for a membrane for cell culture according to any one of claims 1 to 6 and the membrane. 目的とする細胞が角膜上皮細胞、皮膚表皮細胞、粘膜上皮細胞及び気道上皮細胞からなる群から選択されることを特徴とする請求項7に記載の方法。   8. The method according to claim 7, wherein the target cell is selected from the group consisting of corneal epithelial cells, skin epidermal cells, mucosal epithelial cells and airway epithelial cells. 目的とする細胞を気液界面培養で培養する請求項7に記載の方法。   The method according to claim 7, wherein the target cell is cultured by gas-liquid interface culture. 気液界面培養を傾斜振動培養で行う請求項9に記載の方法。   The method according to claim 9, wherein the gas-liquid interface culture is performed by inclined vibration culture. 傾斜振動培養を6〜10rpmの速度で3〜12日間培養することを特徴とする請求項10に記載の方法。   The method according to claim 10, wherein the tilted vibration culture is cultured at a speed of 6 to 10 rpm for 3 to 12 days.
JP2005172996A 2004-06-11 2005-06-13 Cell culture membrane support device Active JP4260139B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020040042860A KR100595940B1 (en) 2004-06-11 2004-06-11 Device for holding a membrane used in culturing cells

Publications (2)

Publication Number Publication Date
JP2005348736A JP2005348736A (en) 2005-12-22
JP4260139B2 true JP4260139B2 (en) 2009-04-30

Family

ID=35583691

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005172996A Active JP4260139B2 (en) 2004-06-11 2005-06-13 Cell culture membrane support device

Country Status (2)

Country Link
JP (1) JP4260139B2 (en)
KR (1) KR100595940B1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007029676A1 (en) * 2005-09-07 2007-03-15 Arblast Co., Ltd. Biological tissue sheet and method for preparation thereof
JP5157139B2 (en) * 2006-11-28 2013-03-06 大日本印刷株式会社 Cell transplant material
JP5181172B2 (en) * 2007-02-21 2013-04-10 国立大学法人富山大学 Method for producing cultured stratified epithelial sheet
FR2927632B1 (en) * 2008-02-14 2013-07-19 Basf Beauty Care Solutions F CORNEA AND MUQUEUSE RECONSTRUCTED.
JP2011135836A (en) * 2009-12-28 2011-07-14 Cell Remover:Kk Cell culture base material
JP5835693B2 (en) * 2010-02-05 2015-12-24 株式会社角膜再生研究所 Corneal endothelial cell culture method, method for producing corneal endothelial cell sheet for transplantation, and corneal endothelial cell culture kit
ITFI20130220A1 (en) * 2013-09-20 2015-03-21 Azienda Ospedaliero Universitaria P Isana APPARATUS AND PROCESS FOR THE PREPARATION OF A BIOMYMETIC TISSUE PROSTHESIS OF THE TIMPANIC MEMBRANE
JP6189787B2 (en) * 2014-04-28 2017-08-30 豊田合成株式会社 Cell culture equipment
US11802265B2 (en) * 2015-06-25 2023-10-31 Auckland Uniservices Ltd Tissue culture apparatus and method
CN105331539A (en) * 2015-12-10 2016-02-17 上海市第一人民医院 Cell cultivation model for artificial cornea reconstruction
JP7304022B2 (en) * 2019-10-16 2023-07-06 国立研究開発法人理化学研究所 Cell sheet manufacturing device and cell sheet

Also Published As

Publication number Publication date
KR20050117690A (en) 2005-12-15
JP2005348736A (en) 2005-12-22
KR100595940B1 (en) 2006-07-05

Similar Documents

Publication Publication Date Title
JP4260139B2 (en) Cell culture membrane support device
RU2104039C1 (en) Live skin substituent, method of its preparing and method of live skin lesion treatment
ES2402739T3 (en) Tissue constructs modified by bioengineering and methods to produce and use them
EP0422209B1 (en) Implants for large volumes of cells on polymeric matrices
RU2470611C2 (en) Occluder for transcutaneous transluminal procedure (versions), method of transcutaneous transluminal closing of hole in heart, method of activisation of mammalian tissue vascularisation in vivo and method of activisation of anastomosis place healing
RU2498808C2 (en) Method of treating patient&#39;s oral diseases (versions)
US20080026461A1 (en) Tissue-like organization of cells and macroscopic tissue-like constructs, generated by macromass culture of cells and the method of macromass culture
JP2000189158A (en) Three-dimensional culturing system of cell and tissue
JP2003527170A (en) Method and composition for reconstructing multilayer tissue structure
JPH07102130B2 (en) Chimeric neomorphogenesis of organs by controlled cell transplantation using artificial matrix
JPH11503946A (en) Artificial skin containing a biocompatible substance based on a hyaluronic acid derivative as a support
Murakami et al. The effect of micropores in the surface of temperature-responsive culture inserts on the fabrication of transplantable canine oral mucosal epithelial cell sheets
JP3738273B2 (en) Improved keratinocyte culture and use thereof
JP4061487B2 (en) Transplant material for angiogenesis and method for producing the same
KR100834731B1 (en) A use of amnion as a substrate or basement membrane for cell culture, the method for preparing them and the use thereof
RU2736480C2 (en) Method for production of collagen-laminin matrix for healing of ulcers, burns and wounds of human skin
KR100907323B1 (en) Tissue-like organization of cells and macroscopic tissue-like constructs, generated by macromass culture of cells, and the method of macromass culture
RU2335538C2 (en) Organization of cells similar to tissue and macroscopical designs similar to tissue obtained by means of culture of macromass of cells and method of macromass culture
ES2353990B1 (en) ELABORATION OF ARTIFICIAL FABRICS THROUGH TISULAR ENGINEERING USING FIBRINE AND AGAROSE BIOMATERIALS.
KR0156685B1 (en) Method for testing the effect of drug
JP2003180819A (en) Material for transplant and cellular retention carrier
KR0156571B1 (en) Three dimensional cell and tissue culture system
AU668959C (en) Biotherapeutic cell-coated microspheres
MXPA01005098A (en) Bioengineered tissue constructs and methods for producing and using them

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080729

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20090106

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20090203

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120220

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 4260139

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120220

Year of fee payment: 3

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313117

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120220

Year of fee payment: 3

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130220

Year of fee payment: 4

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130220

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140220

Year of fee payment: 5

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250